NorthWest Biotherapeutics Inc (NWBO)

[catinhat]

Dr. Timothy Cloughesy, GCAR, Glioblastoma trial, KTRA

Hope it's ok to ask this here, given overlap w/Glioblastoma. So I was in/out of KTRA some years back, but kept it on my watchlist. Given the topical overlap with NWBO, anyone here have any $.02 on the name or know it at all?

insert-text-here

"VAL-083, is a "first-in-class" small molecule DNA-targeting agent that is currently being evaluated in a biomarker-driven Phase 2 clinical trial for the treatment of Unmethylated MGMT recurrent glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. We are also exploring VAL-083 in a Phase 2 trial as a therapy for front-line Unmethylated MGMT GBM and we may study other solid tumors, including ovarian cancer and pediatric CNS tumors."